MindMaze and Mount Sinai Health System announce the launch of an at-home tele-neurorehabilitation program for stroke patients, utilizing the FDA-cleared and CE-marked MindMotion GO.
With this system, patients can continue their recovery at home with virtual support from clinicians at Mount Sinai’s Abilities Research Center (ARC).
This initiative expands patient access to MindMotion GO, which has been adopted by the Rehabilitation Innovation team at Mount Sinai since June to provide critical neurorehabilitation across the continuum of care.
Using MindMaze’s gamified digital therapy program, Mount Sinai patients can seamlessly transition between inpatient to outpatient rehabilitation and continue their recovery at home while still receiving support and care from their physical therapists. Designed to keep acute and chronic stroke patients training for longer periods, MindMotion GO guides a complete range of body parts including the upper and lower limbs, hands, and trunk, to improve motor and task functions, a media release from MindMaze explains.
“The COVID-19 pandemic has set back the recovery and rehabilitation of stroke patients worldwide, underscoring the need for cutting-edge digital neurotherapeutics.
“MindMotion GO has enabled thousands of stroke patients to recover within the safety of their homes. We are excited to collaborate with Mount Sinai to expand access to the telerehabilitation solutions patients need and rightly deserve.”
— Tej Tadi, CEO and founder of MindMaze
MindMotion GO features several therapeutic games developed to help clinicians create personalized therapy regimens and provide patients with real-time audio and visual feedback. It also features full-body motion capture technology and hand dexterity hardware, offering therapists a way to monitor the quality of each patient’s movements and provide a tactical level of support similar to being physically present with them.
“With MindMotion GO, we’ve been able to provide our patients with continued access to top-tier telerehabilitation and support despite constant changes in the traditional hospital and treatment settings.
“We look forward to growing this program as we’ve seen our patients enjoy a new level of ownership over their treatment, helping them make great strides in their recovery.”
— David Putrino, PhD, Director of Rehabilitation Innovation for the Mount Sinai Health System
[Source(s): MindMaze, PR Newswire]
Related Content:
MindMotion GO Mobile Neurorehab Therapy System Receives FDA Clearance
